F
ree-fat grafting has become one of the standard procedures for soft-tissue augmentation/reconstruction and rejuvenation. However, fat grafting remains unpredictable and technique-dependent, and there are many aspects to elucidate, such as how the adipose grafts survive and retain their volume over long periods without microsurgical revascularization. Although infiltrated histiocytes (possibly meaning macrophages) were once proposed to acquire lipid material and eventually replace all adipose tissue of the graft that had disappeared ("host replacement theory"), 1 the "cell survival theory," which states that transplanted living cells partly survive and remain alive for a long time after grafting, has been generally accepted. [1] [2] [3] [4] [5] [6] Based on the widespread idea that the number of viable adipocytes in a graft correlates with the ultimate volume of persisting fat, many efforts have been made to purify or maximize the number of viable adipocytes. [7] [8] [9] There are various types of cells in subcutaneous adipose tissue, and adipocytes account for only 20 percent or fewer of the total number of cells. 10, 11 We previously reported the orchestrated cell interactions caused by manipulations of adipose tissue such as mechanical injury, ischemia-reperfusion injury, and surgically induced ischemia. [12] [13] [14] [15] In these studies, adipose stem/stromal/progenitor cells (adipose-derived stromal cells) were shown to play pivotal roles in adipose tissue repair/remodeling; they increase in number, contribute to angiogenesis/adipogenesis in response to primary signals released from the injured tissue, and release various secondary growth factors. 16, 17 However, adipose tissue survival/remodeling after nonvascularized fat grafting should differ from that after both mechanical injury and ischemia (partly corresponding to vascularized transposition of the adipose flap) and that after ischemia-reperfusion injury (corresponding to a revascularized free flap with a microsurgical anastomosis).
Our current study was performed to clarify the fate of adipocytes and related cellular events after nonvascularized free-fat grafting. Therefore, we focused on the early phase (0 to 14 days) of the healing process. We analyzed the viability of each cellular component of human fat tissue with in vitro assays and organ culture (in vitro simulation of human fat grafting), and we very carefully evaluated adipocyte viability in fat grafts in mice (in vivo assay).
PATIENTS AND METHODS

Human Cell Isolation and Culture
Human liposuction aspirates were obtained from 10 healthy female donors aged 41.9 Ϯ 10.4 years (mean Ϯ SD) and with an average body mass index of 23.0 Ϯ 2.5 kg/m 2 who underwent elective liposuction of the abdomen or thighs. Each patient provided written informed consent, and the research protocol was approved by the ethics committee of the University of Tokyo, School of Medicine. Stromal vascular fraction containing adipose-derived stromal cells was isolated from the aspirated fat tissue as described. 10 Briefly, the fatty portion of the aspirated fat tissue was washed with phosphate-buffered saline and digested in 0.075% collagenase (Wako Pure Chemical Industries, Ltd., Osaka, Japan) in phosphate-buffered saline at 37°C for 30 minutes on a shaker. Mature adipocytes and connective tissue were separated from pellets by centrifugation (800 g for 10 minutes) and discarded. The pellets were resuspended in phosphate-buffered saline and filtered through a 100-m mesh, followed by centrifugation (800 g for 10 minutes) to spin down stromal vascular fraction cell pellets. The stromal vascular fraction cells were plated at a density of 5 ϫ 10 5 nucleated cells/100-mm dish and cultured at 37°C in an atmosphere of 5% carbon dioxide in humid air. Cells were grown in a control medium (Dulbecco's Modified Eagle's Medium; Nissui Pharmaceutical Co., Ltd., Tokyo, Japan) containing 10% fetal bovine serum. Primary cells were cultured for 7 days and were defined as passage 0. The medium was replaced every 3 days. Cells were passaged every week by trypsinization. Adipose-derived stromal cells at passages 1 to 3 were used in the following experiments.
To isolate human vascular endothelial cells from aspirated adipose tissue, the stromal vascular fraction cells were plated at a density of 2 ϫ 10 6 nucleated cells/100-mm dish and cultured in endothelial growth medium-2 (Cambrex, Walkersville, Md.) with 2% fetal bovine serum for 2 days. Attached cells were harvested by trypsinization and incubated with phycoerythrin-conjugated mouse anti-human CD31 antibody (BD Biosciences, San Jose, Calif.), followed by incubation with anti-phycoerythrin magnetic microbeads (Miltenyi Biotec GmbH, Land Nordrhein-Westfalen, Germany). CD31 ϩ cells were isolated with a magnetic cell sorter (AutoMACS separator; Miltenyi Biotec). The primary cells were cultured in endothelial growth medium-2 for 7 days and were defined as passage 1. Endothelial cells at passages 3 to 5 were used in this study. To obtain adipocytes (experimentally differentiated adipose-derived stromal cells), adipose-derived stromal cells were incubated in adipogenic medium (control medium containing 0.5 mM isobutyl-methylxanthine, 1 M dexamethasone, 10 M insulin, and 200 M indomethacin) for 3 days and then maintained in the control medium for another 10 days.
Flow Cytometry
The following monoclonal antibodies conjugated to fluorochromes were used: anti-CD31-phycoerythrin, anti-CD34 -phycoerythrin-Cy7, and anti-CD45-fluorescein isothiocyanate (BD Biosciences). To distinguish dead cells from live cells, 7-aminoactinomycin D (7AAD) staining was used. Multicolor flow cytometry was performed with an LSR II (BD Biosciences), and cell composition percentages and cell numbers were calculated according to surface marker expression profiles.
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In Vitro Cell Death Assay
Adipose-derived stromal cells, experimentally differentiated adipose-derived stromal cells (adipocytes), and endothelial cells were cultured under ischemia-mimicking conditions (1% oxygen with no serum), and apoptosis (annexin V) and necrosis (propidium iodide) were evaluated with a fluorescent microscope. All nuclei were counterstained with Hoechst 33342 (Dojindo, Kumamoto, Japan) (n ϭ 5). Images acquired with a fluorescence microscope (Keyence, Osaka, Japan) were used to count apoptotic and necrotic cells.
Organ Culture of Aspirated Adipose Tissue and Measurement of Viable Adipocytes
Aspirated adipose tissue (1 g) was cultured in 1 ml of serum-free control medium under hypoxia (1% oxygen). A cover glass was placed over the fat to prevent exposure to the air. At each time point (days 0, 1, 2, 3, 5, and 7), the cultured adipose tissue was fixed (Zinc Fixative; BD Biosciences), embedded in paraffin, and sectioned at 6 m for immunohistochemistry using guinea pig antiperilipin antibody (Progen Biotechnik GmbH, Heidelberg, Germany) and Alexa Fluor 488 -conjugated secondary antibody (Molecular Probes, Eugene, Ore.). Perilipin-positive cells (viable adipocytes) were detected and counted under a fluorescence microscope.
Animal Models
Animals were cared for in accordance with our institutional guidelines. Six-week-old C57BL/6J mice were anesthetized with intraperitoneal pentobarbital (50 mg/kg), and the subcutaneous inguinal fat pad was harvested with a 1-cm incision. The fat pad (150 to 200 mg) was small like a fat injection material and transplanted by inserting the fat pad into a small pocket made under the scalp of the same mouse. After 0, 1, 2, 3, 5, 7, or 14 days, the adipose autografts were examined with immunohistochemistry.
Immunohistochemistry for Grafted Fat Tissue
Harvested adipose tissue was fixed (Zinc Fixative), embedded in paraffin, and sectioned at 6 m for immunohistochemistry. The following primary antibodies were used: rabbit anti-Ki67 (Thermo Fisher Scientific, Fremont, Calif.) and guinea pig antiperilipin (Cedarlane Laboratories, Burlington, Ontario, Canada). Isotypic antibody was used as a negative control for each staining. For visualization, Alexa Fluor 488 -or Alexa Fluor 568 -conjugated secondary antibodies (Molecular Probes) were used. Nuclei were stained with Hoechst 33342.
Statistical Analysis
Data are expressed as mean Ϯ SEM. Results were analyzed using Ekuseru-Toukei 2008 (SSRI, Tokyo, Japan). Comparisons of multiple groups were made using one-way analysis of variance with the Bonferroni multiple t test. Values of p Ͻ 0.05 were considered statistically significant.
RESULTS
Analyses of Stromal Vascular Fraction Cells from Lipoaspirates Stored in a Refrigerator for 0 to 7 Days
Lipoaspirates were stored in a refrigerator (4°C) for various periods (0, 1, 2, 3, 5, or 7 days), and the stromal vascular fraction was isolated and analyzed. Freshly isolated stromal vascular fraction from human aspirated adipose tissue contained all cell types in adipose tissue other than mature adipocytes. Flow cytometric analysis showed that stromal vascular fraction contained CD45 ϩ hematopoietic cells (circulating leukocytes and adipose-resident hematopoietic cells) and CD45
Ϫ adipose-derived cells (Fig. 1,  above) . The CD45
Ϫ component was further separated into CD45
ϩ adipose-derived stromal cells, and CD45
Ϫ /CD31 Ϫ /CD34 Ϫ other cells ( Fig. 1, above) . The viable cell composition of the stromal vascular fraction on day 1 differed considerably from that obtained from fresh adipose tissue ( Fig. 1, center) . The most remarkable difference was the percentage of endothelial cells, which were markedly decreased on the next day ( Fig. 1, center) . Analysis of total cell numbers (both viable and dead) in the stromal vascular fraction revealed that viable endothelial cells and viable hematopoietic cells were significantly decreased in number during the first 24 hours, whereas the number of viable adipose-derived stromal cells (CD45 Ϫ /CD31 Ϫ /CD34 ϩ ) was not significantly different ( Fig. 1, below) . The viability of hematopoietic cells and endothelial cells was much lower than the viability of adipose-derived stromal cells throughout the experiment period, although adipose-derived stromal cell viability was also low from day 3. Thus, human endothelial cells and hematopoietic cells died easily under ischemic conditions, but more adipose-derived stromal cells remained viable for up to 3 days.
In Vitro Analyses of Human Adipose-Derived Stromal Cells, Adipocytes, and Endothelial Cells Cultured under Ischemia-Mimicking Conditions
To further examine the cellular response to ischemia (hypoxia and low nutrients), adiposederived stromal cells, experimentally differentiated adipose-derived stromal cells (called adipocytes in this study), and endothelial cells were cultured under ischemia-mimicking conditions (1% oxygen with no serum) for 0, 12, 24, 48, or 72 hours, and cell apoptosis and necrosis were examined by staining with annexin V and propidium iodide, respectively (Fig. 2, above) . Within 24 hours, adipocytes underwent apoptosis (annexinpositive/propidium iodide-negative) or necrosis (propidium iodide-positive), and endothelial cells lost their adherence to the culture dish. Only adipose-derived stromal cells remained intact up to 72 hours (Fig. 2, below) . Thus, endothelial cells underwent apoptosis as early as 12 hours, and adipocytes most easily died under ischemia compared with endothelial cells and adipose-derived stromal cells. Adipose-derived stromal cells remained viable up to 72 hours under ischemic conditions.
Adipocyte Viability in Organ Culture of Human Adipose Tissue under Ischemia-Mimicking Conditions
Next, to further analyze the viability of human adipocytes under ischemia, organ culture of aspirated adipose tissue was performed. Adipose tissue cultured under ischemia-mimicking conditions (1% oxygen with no serum) was fixed at each time point (day 0, 1, 2, 3, 5, or 7) and immunostained for perilipin (Fig. 3, above) . Because dead adipocytes were not stained with perilipin, we defined round-shaped cells that were strongly positive for perilipin as viable adipocytes. The number of viable adipocytes was significantly decreased during the first day, and most adipocytes lost their strong expression of perilipin by day 3, suggesting that mature adipocytes readily died under ischemic conditions (Fig. 3, below) .
Viability of Adipocytes in Nonvascularized Grafted Fat Tissue in a Mouse Model
To evaluate adipocyte viability after fat grafting, we used a mouse model for nonvascularized fat grafting in which the inguinal fat pad was ex- is colored in red, the area filled with dying adipocytes (weakly positive) is shown in yellow, and the area of dead adipocytes or connective tissue (negative area) is shown in black. The red area was dramatically reduced on day 1, and most of the yellow area had disappeared by day 5. It was revealed that only some adipocytes located less than 300 m from the tissue surface remained alive, and all other adipocytes died within a few days after fat grafting. Scale bars ϭ 1 mm. (Below) Sequential changes in the live adipocyte
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Then, the grafted fat section was classified into three areas and coded in different colors: viable adipocyte area (red), dying adipocyte area (yellow), and dead adipocyte area or connective tissue area (black) (Fig. 4, above) . Surprisingly, viable adipocytes were dramatically decreased as early as day 1, and they were detected only in the peripheral area (Ͻ300 m from the surface) of the transplanted fat tissue, suggesting a better microenvironment in the periphery likely because of plasma diffusion from the surrounding intact tissue (Fig.  4) . From day 2 to day 5, the number of viable adipocytes gradually decreased, and dying adipocytes completely lost perilipin expression, resulting in fewer adipocytes that were weakly positive for perilipin on day 5. Most adipocytes died, except for those on the peripheral edge. After day 7, however, resurgence was observed in the ratio of viable adipocyte area to the entire adipose tissue area (Fig. 4, below) , suggesting that regenerative adipogenic changes, such as increasing numbers and size of new adipocytes, began from the peripheral dead area. Indeed, Ki67-positive proliferating cells were detected around the junction between the viable adipocyte area and the dead adipocyte area on days 5 and 7, suggesting proliferation of precursor cells (Fig. 5) .
DISCUSSION
Over the years, we have performed flow cytometry to analyze the cellular composition of the stromal vascular fraction. We observed differences between the stromal vascular fraction examined on the day of surgery and the stromal vascular fraction on the next day. As shown in Figure 1 and Supplemental Digital Content 1, http://links.lww. com/PRS/A480, our current experiments indeed showed that human adipose-derived stromal cells survived well under ischemic conditions compared with endothelial cells and hematopoietic cells, suggesting that each cell type has a different tolerance to ischemic stress. This was also demonstrated in mice in our previous study using surgically induced ischemic adipose tissue.
14 The cell death assay using adipocytes (differentiated adipose-derived stromal cells), and perilipin staining of organ-cultured adipose tissue, showed that adipocytes died as early as the first day of ischemia, endothelial cells died second, and finally adipose-derived stromal cells died on day 3. Thus, our in vitro results do not support the cell survival theory; the results suggested that a large proportion of adipocytes in a nonvascularized fat graft unlikely survive even when the graft is placed on a good recipient bed. Nonvascularized fat grafts obtain nutrients and oxygen through plasmatic diffusion from surrounding tissues until vascularization is restored by ingrowth and reconnection of capillaries and vessels. Although numerous previous studies have demonstrated survival or neogenesis of adipose tissue, most studies determined whether adipocytes were viable only by their morphology. 7, 18 In a previous study, 7 human aspirated fat tissue was grafted and histologically characterized into three zones at 3 to 4 weeks after grafting: the peripheral zone (viable adipocytes), the intermediate zone (inflammatory processes), and the central zone (necrotic zone). The study determined the graft viability based on the morphology of adipocytes and concluded that the viable region of the graft is approximately 1.5 Ϯ 0.5 mm from the edge and that 60 percent of the adipocytes in the viable zone die. In other studies, cell viability and apoptosis assays were performed with the entire piece of adipose tissue, and adipocytes were not specifically evaluated. 19 However, we cannot discriminate viable adipocytes from dead adipocytes with standard stains such as hematoxylin and eosin; a dead adipocyte (a round lipid droplet) can be easily mistaken for a live adipocyte. Because an adipocyte has a large size (50 to 150 m diameter), a single adipocyte is sliced into many histologic sections (with a regular thickness of 3 to 10 m), and thus a single histologic section does not generally show most nuclei of healthy adipocytes. Therefore, we cannot confirm a healthy adipocyte by its shape or the presence of a nucleus. However, we recently found that we can very easily discriminate living and dead adipocytes by immunostaining for perilipin, which was used in this study. Perilipin is a protein that coats lipid droplets in adipocytes, and it has been demonstrated that dead adipocytes are negative for perilipin. 20 -22 We also evaluated adipocyte viability after fat grafting using a mouse model, which is the ultimate and most clinically relevant goal of this study. We very carefully evaluated adipocyte viability by killing the mice on almost every single postoperative day and meticulously evaluating the staining Fig. 4. (Continued) area (ratio of the area strongly positive for perilipin to the whole cross-sectional area) (n ϭ 6). The area filled with viable adipocytes was significantly decreased on day 1, suggesting that grafted adipocytes began to die within 1 day. However, the viable area began to increase from day 7, suggesting that adipogenesis had begun within the first week. Statistical analysis was performed among the seven time points (*p Ͻ 0.05).
Volume 129, Number 5 • Fate of Adipocytes after Fat Grafting intensity of each adipocyte, because several days were required for an adipocyte to completely lose its perilipin staining after death. Adipocytes that were weakly positive for perilipin may have already been dead (but were called dying adipocytes in this study), because all such cells completely lost perilipin staining at a later stage, as seen on the histology performed on day 5. Our results clearly indicated that only peripherally located adipocytes survived and that the depth of the viable zone was approximately 300 m from the graft edge: almost all adipocytes located deeper than 300 m died within a few days after grafting. This means that we observed much fewer surviving cells compared with a previous report that used standard histology. 7 From day 2 to day 5, no remarkable changes in the viable adipocyte zone were observed, but the dying adipocyte zone (weakly positive for perilipin) decreased in size day to day. Immunohistology on day 5 showed the percentage of adipocytes in the graft that actually survived, although the survival rate should theoretically differ depending on the size of the graft and the conditions (e.g., vascularity, tissue contact) of the surrounding tissue. Indeed, we noticed a difference in viable zone thickness between the overlying skin side and the underlying bone side of the graft; the viable zone thickness was frequently thicker on the skin side, suggesting better vascularity of the contacted tissue.
The in vivo experiment provided another intriguing insight into fat graft fate: regeneration. The number of proliferating cells increased after day 3, and the viable adipocyte area began to increase in size from day 7, suggesting regenerative changes to repair the tissue. Small (Ͻ50 m in diameter) adipocytes strongly stained for perilipin-indicating newly born adipocytes-were observed in the inner border zone of the viable peripheral area after day 5. This suggests that tissue-resident stem/progenitor cells (such as adipose-derived stromal cells) did not die at least in the peripheral part of the graft and started to repair the tissue by adipogenesis and angiogenesis. Our in vitro studies indicating strong tolerance of adipose-derived stromal cells to severe ischemia support this notion. Bone marrow-derived precursors may also be involved in the repair process, but further analysis is needed to elucidate the type and origin of the proliferating cells.
Considered together, we now understand that adipocyte death does not mean adipose tissue necrosis, but can trigger a regeneration cascade; in contrast, death of both adipocytes and adipose precursors (adipose-derived stromal cells) theoretically results in adipose tissue necrosis. Conse- Plastic and Reconstructive Surgery • May 2012 quently, we observed three zones from the periphery to the center of the graft (Fig. 6 ): the surviving area (adipocytes survived), the regenerating area (adipocytes died, adipose-derived stromal cells survived, and dead adipocytes were replaced with new ones), and the necrotic area (both adipocytes and adipose-derived stromal cells died). Replacement of differentiated cells after grafting may be common in other nonvascularized composite tissue grafts in plastic surgery such as skin grafts or bone grafts. Many parts of the connective tissue can be preserved as a scaffold, but all differentiated cells (located more than 300 m from the surface) may die and be replaced by those of the next generation derived from tissue-specific stem/progenitor cells, depending on the microenvironment. However, the distance of plasmatic diffusion is strictly limited because of a gradient of oxygen and nutrients, and thus regeneration is usually incomplete, leading to substantial tissue atrophy and/or dysfunction after nonvascularized grafting.
CONCLUSIONS
We show convincing evidence of very dynamic remodeling of adipose tissue after nonvascularized grafting. Most adipocytes in free grafts died shortly after transplantation, but resident stem/progenitor cells remained alive or became activated, and many adipocytes were regenerated (replaced dead cells with new adipocytes), depending on the microenvironment. Our observations may lead to a paradigm shift because it has been generally accepted that grafted adipocytes survive without replacement. Our body has a biological system termed "compensatory proliferation" for physiologic turnover of any tissue or organs 23 ; in response to cell apoptosis, neighboring progenitor cells are activated for tissue homeostasis. Even for accidental cell death, our body likely has a similar system to properly respond to the emerging event, and we can explore new therapeutic approaches by dissecting and manipulating the underlying mechanisms of the self-repairing system. 
F
at grafting remains one of the most controversial procedures in plastic surgery because there is no standardized technique used by plastic surgeons to harvest, process, and place fat grafts. In addition, and most importantly, how the fat grafts survive after they are transplanted in vivo remains unclear and needs to be determined. The present study was conducted by Dr. Kotaro Yoshimura's group from the University of Tokyo, one of the most active teams in the field of fat grafting and adipose stem/stromal/progenitor cell (adiposederived stromal cell) research. The study, composed of two parts, is another example of an important and well-conducted study in understanding the mechanism of how fat grafts survive after transplantation. In the in vitro study, adipocytes from experimentally differentiated adipose-derived stromal cells and endothelial cells were cultured under ischemic conditions. The results show that adipocytes are most susceptible to death under ischemic conditions as early as 12 hours, but adipose-derived stromal cells would remain viable for 72 hours. The in vivo study shows that most adipocytes in the graft site begin to die on day 1 and only some of the adipocytes located within 300 m of the tissue edge would survive. The number of proliferating cells increases from day 3, and increases in viable adipocyte areas can be detected from day 7. This would suggest that repair or regeneration of dead adipose tissue has begun after fat grafting in vivo. The in vivo study also shows three zones after fat grafting from the periphery to the center of the fat grafts: the surviving area (adipocytes survived), the regenerative area (adipocytes died, adipose-derived stromal cells survived, and dead adipocytes were replaced with new ones), and the necrotic area (both adipocytes and adipose-derived stromal cells died). 1 The study appears to show convincing evidence that there is a dynamic remodeling of adipose tissue after conventional fat grafting. Based on the present study, and studies from the same group published previously, the authors have proposed a new theory of how fat grafts survive, the so-called host replacement theory, because it is indeed the case that adipose-derived stromal cells play an important role in fat graft survival. Such a new theory would at least partially explain some of the promising clinical results after cell-assisted lipotransfer proposed by Dr. Yoshimura's group and used by some of our colleagues worldwide. 2, 3 For the past decade or so, the "cell survival theory" has been well accepted by most plastic surgeons to describe how fat grafts survive after they are transplanted in vivo. This theory states that transplanted living adipocytes can survive once they receive adequate nutrients and are incorporated into adjacent vascularized tissue in the recipient site. 4 One previous study shows that human fat may survive after it is grafted to a recipient site and can histologically be characterized into three zones approximately 3 to 4 weeks after grafting. These zones are the peripheral zone (viable adipocytes), the intermediate zone (inflammatory area), and the central zone (necrotic adipocytes). The viable region of the fat grafts is approximately 1.5 Ϯ 1 .5 mm from the adjacent tissue edge, and approximately 60 percent of the adipocytes in the viable zones would eventually die. 5 Based on this theory, the fat grafts should be viable before they are transplanted in vivo and should be placed in a unique fashion that allows fat grafts to have a maximal amount of contact with adjacent living tissue. Therefore, the surgeons who perform fat grafting have refined their technique to harvest and process fat grafts, and to place fat grafts in an 
